{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:30:57Z","timestamp":1759177857629,"version":"3.37.3"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T00:00:00Z","timestamp":1593648000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI13C1232"],"award-info":[{"award-number":["HI13C1232"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235418","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T17:32:25Z","timestamp":1593711145000},"page":"e0235418","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tacrolimus trough levels higher than 6 ng\/mL might not be required after a year in stable kidney transplant recipients"],"prefix":"10.1371","volume":"15","author":[{"given":"Hee-Yeon","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Young","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yena","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Ha","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9117-2278","authenticated-orcid":true,"given":"Jae Berm","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Woong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Yeup","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Ro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeseok","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Curie","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Hee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun-Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Lim","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4648-0324","authenticated-orcid":true,"given":"Chan-Duck","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"issue":"1","key":"pone.0235418.ref001","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"S Sagedal","year":"2004","journal-title":"Kidney Int"},{"issue":"6","key":"pone.0235418.ref002","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1086\/528718","article-title":"Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation","volume":"46","author":"SK Arthurs","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0235418.ref003","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/TP.0b013e318197c17d","article-title":"The decade of polyomavirus BK-associated nephropathy: state of affairs","volume":"87","author":"E Ramos","year":"2009","journal-title":"Transplantation"},{"issue":"2","key":"pone.0235418.ref004","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","article-title":"Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence","volume":"12","author":"J Sellares","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"pone.0235418.ref005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.23876\/j.krcp.2018.37.2.167","article-title":"Long-term prognosis of BK virus-associated nephropathy in kidney transplant recipients","volume":"37","author":"WY Park","year":"2018","journal-title":"Kidney Res Clin Pract"},{"issue":"4","key":"pone.0235418.ref006","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1432-2277.2005.00080.x","article-title":"Assessing the relative risk of cardiovascular disease among renal transplant patients receiving tacrolimus or cyclosporine","volume":"18","author":"AG Jardine","year":"2005","journal-title":"Transpl Int"},{"issue":"8","key":"pone.0235418.ref007","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/TP.0b013e318186f98a","article-title":"Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: the fixed-dose concentration-controlled trial","volume":"86","author":"T van Gelder","year":"2008","journal-title":"Transplantation"},{"issue":"25","key":"pone.0235418.ref008","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1056\/NEJMoa067411","article-title":"Reduced exposure to calcineurin inhibitors in renal transplantation","volume":"357","author":"H Ekberg","year":"2007","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0235418.ref009","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/ajt.12191","article-title":"Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(dagger)","volume":"13","author":"R Bouamar","year":"2013","journal-title":"Am J Transplant"},{"issue":"9","key":"pone.0235418.ref010","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/ndt\/16.9.1905","article-title":"Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation","volume":"16","author":"C Staatz","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"pone.0235418.ref011","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1399-0012.2009.01021.x","article-title":"Higher tacrolimus trough levels on days 2\u20135 post-renal transplant are associated with reduced rates of acute rejection","volume":"23","author":"CM O'Seaghdha","year":"2009","journal-title":"Clin Transplant"},{"issue":"10","key":"pone.0235418.ref012","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/tri.12155","article-title":"Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics","volume":"26","author":"AK Israni","year":"2013","journal-title":"Transpl Int"},{"issue":"2","key":"pone.0235418.ref013","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/tri.12699","article-title":"Lower tacrolimus trough levels are associated with subsequently higher acute rejection risk during the first 12 months after kidney transplantation","volume":"29","author":"JJ Gaynor","year":"2016","journal-title":"Transpl Int"},{"key":"pone.0235418.ref014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12659\/AOT.895104","article-title":"Tacrolimus Trough Levels as a Risk Factor for Acute Rejection in Renal Transplant Patients","volume":"21","author":"JM Arreola-Guerra","year":"2016","journal-title":"Ann Transplant"},{"key":"pone.0235418.ref015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.12659\/AOT.889858","article-title":"Effect of different tacrolimus levels on early outcomes after kidney transplantation","volume":"19","author":"S Rehman","year":"2014","journal-title":"Ann Transplant"},{"issue":"10","key":"pone.0235418.ref016","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1097\/TP.0000000000000149","article-title":"Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients","volume":"97","author":"KR Richards","year":"2014","journal-title":"Transplantation"},{"issue":"4","key":"pone.0235418.ref017","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/ajt.14504","article-title":"Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation","volume":"18","author":"S Davis","year":"2018","journal-title":"Am J Transplant"},{"issue":"12","key":"pone.0235418.ref018","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.3346\/jkms.2019.34.e103","article-title":"Comparison of Transplant Outcomes for Low-level and Standard-level Tacrolimus at Different Time Points after Kidney Transplantation","volume":"34","author":"HY Jung","year":"2019","journal-title":"J Korean Med Sci"},{"issue":"11","key":"pone.0235418.ref019","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1681\/ASN.2017030287","article-title":"Class II Eplet Mismatch Modulates Tacrolimus Trough Levels Required to Prevent Donor-Specific Antibody Development","volume":"28","author":"C Wiebe","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pone.0235418.ref020","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/ajt.14109","article-title":"Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Randomized Study","volume":"17","author":"P Gatault","year":"2017","journal-title":"Am J Transplant"},{"issue":"11","key":"pone.0235418.ref021","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2009.153","article-title":"Kidney disease: improving global outcomes","volume":"5","author":"KU Eckardt","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"pone.0235418.ref022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.ajkd.2017.07.018","article-title":"Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate-Release Versus Extended-Release Tacrolimus in African American Kidney Transplant Recipients","volume":"71","author":"J Trofe-Clark","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"pone.0235418.ref023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2369-15-77","article-title":"KNOW-KT (KoreaN cohort study for outcome in patients with kidney transplantation: a 9-year longitudinal cohort study): study rationale and methodology","volume":"15","author":"J Yang","year":"2014","journal-title":"BMC Nephrol"},{"issue":"4","key":"pone.0235418.ref024","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/TP.0000000000000085","article-title":"Pretransplant dialysis duration and risk of death after kidney transplantation in the current era","volume":"98","author":"I Helantera","year":"2014","journal-title":"Transplantation"},{"issue":"19","key":"pone.0235418.ref025","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1056\/NEJMra0902710","article-title":"Hemodialysis","volume":"363","author":"J Himmelfarb","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0235418.ref026","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1046\/j.1523-1755.1999.00273.x","article-title":"Inflammation enhances cardiovascular risk and mortality in hemodialysis patients","volume":"55","author":"J Zimmermann","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"pone.0235418.ref027","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ki.1997.429","article-title":"Technical note. The serum concentration of the advanced glycation end-product N epsilon-(carboxymethyl)lysine is increased in uremia","volume":"52","author":"TP Degenhardt","year":"1997","journal-title":"Kidney Int"},{"issue":"4","key":"pone.0235418.ref028","doi-asserted-by":"crossref","first-page":"e0191921","DOI":"10.1371\/journal.pone.0191921","article-title":"Artificial neural network model for predicting the bioavailability of tacrolimus in patients with renal transplantation","volume":"13","author":"K Thishya","year":"2018","journal-title":"PLoS One"},{"issue":"9","key":"pone.0235418.ref029","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1111\/bcp.13980","article-title":"Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients","volume":"85","author":"S Anutrakulchai","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"pone.0235418.ref030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1742-7843.2012.00892.x","article-title":"Identification of factors affecting tacrolimus level and 5-year clinical outcome in kidney transplant patients","volume":"111","author":"IW Kim","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"pone.0235418.ref031","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.transproceed.2011.11.004","article-title":"Impact of cytochrome P450 3A and ATP-binding cassette subfamily B member 1 polymorphisms on tacrolimus dose-adjusted trough concentrations among Korean renal transplant recipients","volume":"44","author":"JH Cho","year":"2012","journal-title":"Transplant Proc"},{"issue":"1","key":"pone.0235418.ref032","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ndt\/gft299","article-title":"The ERA-EDTA Database on Recurrent Glomerulonephritis following renal transplantation","volume":"29","author":"J Floege","year":"2014","journal-title":"Nephrol Dial Transplant"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235418","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T09:52:00Z","timestamp":1696326720000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235418"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,2]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235418","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,7,2]]}}}